Provide your details below to request scholarly review comments.
×
Verified Request System ®
Order Article Reprints
Please fill in the form below to order high-quality article reprints.
×
Scholarly Reprints Division ®
− Abstract
Diabetic foot is a major chronic complication of diabetes mellitus and represents a leading cause of hospitalisation, infection and non- traumatic lower limb amputation worldwide. The pathogenesis is multifactorial primarily involving peripheral neuropathy, peripheral arterial disease, impaired immunity and poor glycemic control which together predispose patients to ulceration and delayed wound healing. This review of literature aims to summarise current evidence regarding epidemiology, risk factors clinical evaluation and treatment strategies for diabetic foot disease. The literature consistently demonstrates that early identification of at-risk patients through routine screening and structured risk stratification significantly reduces ulcer occurrence. Management of established diabetic foot ulcers requires a multi-disciplinary approach combining glycemic control, infection management using culture guided antimicrobial therapy, regular wound debridement, appropriate wound dressings and appropriate offloading techniques.In patients with associated ischaemia, timely vascular assessment followed by endovascular or surgical revascularisation is critical for limb salvage. Advanced adjunctive therapies including negative pressure wound therapy, bioengineered skin substitutes and growth factor- based treatments have shown beneficial outcomes in selected cases. Overall, comprehensive preventive programs and standardised multidisciplinary treatment protocols remain essential for reducing amputation rates and improving functional outcomes in patients with diabetic foot disease.
− Explore Digital Article Text
# Introduction
Diabetes remains a major global health challenge, driving significant morbidity, mortality, and economic strain. Among its many complications, diabetic foot also represents one of the most debilitating outcomes, with diabetes and serving as the leading cause of non-traumatic lower limb amputation worldwide.\[1,2\]
WHO defines diabetic foot as Infection, ulceration or destruction of deep tissues associated with neurological abnormalities and various degrees of peripheral vascular diseases in the lower limb.\[1,2\] Diabetic foot ulcers emerge from a complex interaction of peripheral neuropathy, peripheral arterial disease, and impaired wound healing, usually exacerbated by infection.\[1,2\] Beyond localised tissue damage, diabetic foot ulceration reflects widespread systemic vascular disease and increases risk of cardiovascular morbidity and early mortality. Major lower limb amputations carry a grave prognosis with post-amputation five year mortality exceeding 50% in patients with diabetes.\[1,2\]
In India, diabetic foot disease represents a particularly significant public health burden, with an estimated 40,000 amputations performed annually. A large proportion of these amputations are neuropathic in origin and complicated by secondary infection, many of which are potentially preventable.\[2\]
Several factors predict poor outcomes in individuals with diabetic foot ulcer, including severity, prolonged duration, infection, peripheral arterial disease, neuropathy, chronic kidney disease, cardiovascular disease, smoking, and male gender.\[1,2\] These variables influence healing rates, recurrence, and likelihood of progression to major amputation or death\[1,2\]. In India sociocultural factors such as barefoot walking, low socioeconomic status, illiteracy, delayed healthcare seeking and reliance on alternative systems of medicine further contribute to late presentation and poor outcomes\[2\].
Effective management of diabetic foot ulcers and their associated complications requires a comprehensive, evidence-based approach\[1,2\]. Core components of treatment include appropriate pressure offloading, prompt and adequate control of infection, timely revascularisation (when indicated), surgical assessment (where necessary), optimisation of glycemic control and systematic management of coexisting medical conditions\[1,2\]. Given the multifactorial pathophysiology of diabetic foot disease, improved clinical outcomes are more likely when care is delivered through a coordinated, multidisciplinary team approach involving interprofessional collaboration\[1,2\].
# REVIEW OF LITERATURE
## Burden of Diabetic Foot Disease
Hyperglycaemia is associated with various complications, both microvascular- including nephropathy, neuropathy, and retinopathy and macrovascular complications such as coronary artery disease, stroke, and peripheral arterial disease\[1,2\]. Among these, diabetic foot disease represents one of the most severe and disabling complications. Diabetes is a leading cause of non-traumatic lower-extremity amputations, with non-healing foot ulcers frequently preceding limb loss\[1,2,10\].The lifetime risk of developing a foot ulcer in individuals with diabetes ranges between 15% and 20% \[1,2,3\]. With 15% of these ulcers progressing to foot or limb amputation \[1-3\]. Population-based studies report an annual incidence of diabetic foot ulcers ranging from 0.5% to 3%, while prevalence varies between 2% and 10% \[\[1-3\]. Approximately 45–60% of diabetic foot ulcers are neuropathic, while nearly 45% exhibit combined neuropathic and ischemic components \[1,2,3\]. Infection is implicated in nearly half of lower-limb amputations in diabetic patients \[1,2,3\].
## Risk Factors
Diabetic foot ulcers arise from an interaction of multiple factors. With peripheral neuropathy comes a loss of sensation, which allows repeated trauma to go unnoticed. Motor neuropathy causes muscle imbalance and foot deformities, resulting in abnormal plantar pressure and callus formation, while autonomic neuropathy reduces sweating, causing dry and fissured skin\[1,2\].Arterial insufficiency further complicates neuropathic ulcers by impairing tissue perfusion and delaying wound healing. Mechanical stress at the wound site plays a significant role in ulcer persistence \[1,2,4\]. Additional risk factors include poor glycemic control, long duration of diabetes, trauma, inappropriate footwear, callus formation, history of previous ulceration or amputation, advancingage, visual impairment, chronic kidney diseaseand poor nutritional status\[1,2,10\]. Infections contribute to chronicity by furtherworsening wound healing leading to a non healing ulcer. Interestingly, a deficiency of Vitamin D is an emerging risk factor for diabetic foot infection \[1,2,5\].
## Classification of Wounds
The Red–Yellow–Black wound classification system by Marion Laboratories categorizes wounds based on the following characteristics \[1,2\]:
• **Necrotic tissue:** Black or dark green in colour, which may be dry or infected
• **Sloughy tissue:** A yellow, glutinous tissue composed of wound exudate and debris, often mistaken for infection.
• **Granulating tissue:** Red, vascular tissue indicating active healing
• **Epithelializing tissue:** Pink in colour, indicating epithelium growing over the wound by keratinocyte migration from wound margins
The presence of devitalised tissue or critical colonisation prevents chronic wounds from healing \[1,2,6\] hence, necessitates removal through debridement of tissue. However, debridement may be contraindicated in purely arterial ulcers \[1,2,3,11\]. With regular excision of necrotic tissue and surrounding callus we are likely to see accelerated wound healing and an increased likelihood of complete secondary closure \[1,2,3\].
## Grading of Diabetic Foot Ulcers
Wound grading is performed using Wagner’s classification or the University of Texas wound classification system \[1,2\]. It includes wound depth, infection, and ischemia. To adequately treat am ulcer, a thorough wound assessment is necessary including documentation of the ulcer location, size, depth, wound margins, base, drainage, colour, odour, pain, and progression \[1,2\].
## Microbiology of Diabetic Foot Infections
Hyperglycaemia, impaired immune response, neuropathy, and peripheral arterial disease predispose patients to diabetic foot infections \[1,2,7\].
Diabetic foot infections may involve aerobic, anaerobic, or fungal organisms. With both mono-microbial and poly-microbial infections being quite common \[1-3\]. Organisms that most commonly infect diabetic foot ulcers include *Staphylococcus aureus*, *Escherichia coli*, and *Pseudomonas aeruginosa*,\[1,2,3,44\] with both gram positive and gram negative bacteria showing a similar predominance. Due to theregional variability in microbial patterns, culture-guided antibiotic therapy is required for adequate resolution\[1,2\].
<figure data-latex-placement="tbp">
<img src="https://doc.journalspress.com/kizox8_226766/author_package/media/image1.jpeg" style="height:75.0%" />
</figure>
# DISCUSSION
Diabetic foot disease remains one of the most feared and debilitating complications of diabetes mellitus. It is associated with prolonged hospitalisations, substantial financial burden, repeated surgical interventions, and a persistent risk of limb loss, all of which significantly affect the physical and psychological well-being of patients. The possibility of amputation and the subsequent experience of phantom limb pain further contribute to emotional distress and reduced quality of life. Consequently, diabetic foot disease continues to pose a major challenge for patients, caregivers, and healthcare systems\[1,2\].
Clinically, the diabetic foot is characterised by a classical triad of **neuropathy, ischaemia, and infection** with each component contributing to ulcer formation, progression, and poor healing outcomes. These factors rarely act in isolation; instead, their coexistence creates a complex pathological environment that predisposes the foot to breakdown and chronic infection. Preventive strategies therefore are the most effective means of reducing morbidity\[1,2,27\].
Pathogenesis
The development of diabetic foot ulcers is multifactorial, with peripheral neuropathy and ischemia serving as the primary underlying mechanisms. Continuous weight-bearing and shear forces exacerbate tissue damage, leading to progressive ulceration. Charcot arthropathy represents an advanced manifestation of neuropathy, resulting from a combination of motor, sensory, and autonomic dysfunction, ultimately causing joint instability, altered foot architecture, and increased risk of ulceration\[1,2\].
Peripheral vascular disease further compromises wound healing by reducing tissue perfusion. Although atherosclerosis in diabetic patients resembles that seen in non-diabetics, it tends to be more diffuse, occurs earlier, and progresses more rapidly. In diabetic individuals, distal vessels below the knee are more commonly involved, while pedal arteries may remain relatively spared. The coexistence of ischemia and neuropathy significantly increases the risk of ulceration and limb loss\[1,2,31\].
## Infection and Osteomyelitis
Infection in the diabetic foot is a limb-threatening condition due to the unique anatomical characteristics of the foot, including multiple intercommunicating compartments that facilitate rapid spread. The absence of pain due to neuropathy allows continued ambulation, further propagating infection. Soft tissue structures such as fascia, tendons, and muscle sheaths provide little resistance to infection, and the presence of hyperglycemia and ischaemia impairs host defense mechanisms\[1,2\].
Osteomyelitis commonly develops as a result of contiguous spread from deep soft tissue infections and is frequently associated with chronic or longstanding ulcers. Diagnosis can be challenging and requires careful clinical evaluation, supported by imaging and microbiological studies. Probing to bone remains a useful bedside test, while magnetic resonance imaging offers high sensitivity and specificity for detecting bone involvement. Definitive diagnosis requires bone biopsy for culture and histopathology\[1,2,39\].
## Classification and Assessment
Accurate classification of diabetic foot ulcers is essential for guiding management. Diabetic foot lesions are broadly categorized into neuropathic and neuroischemic types, each requiring distinct therapeutic strategies. The University of Texas Wound Classification System is widely accepted due to its ability to incorporate depth, infection, and ischemia \[1,2,<https://pmc.ncbi.nlm.nih.gov/articles/PMC2878694/>\].
## Examination of the Feet
Assessment of the feet is a fundamental component of routine physical examination, particularly in individuals with diabetes. Inspection should focus on identifying features suggestive of neuropathy, including xerosis, fissuring, structural deformities, callus formation, altered foot architecture, ulceration, dilated superficial veins, and nail abnormalities. The interdigital spaces must be examined carefully, as lesions in these areas may be easily overlooked\[1,2\]. Clinical signs indicative of significant ischemia include loss of hair over the dorsum of the foot and the presence of dependent rubor\[1,2\]. Palpation: To assess temperature differences, noting areas of unusual warmth or coolness. Peripheral arterial pulses must be evaluated systematically. The dorsalis pedis artery is palpated lateral to the tendon of extensor hallucis longus, while the posterior tibial artery is felt posterior and inferior to the medial malleolus\[1,2\]. Examination should also include palpation and auscultation of the femoral artery to detect bruits. The plantar surface should be assessed for bony prominences, areas of increased pressure, or callosities that may predispose to ulcer formation\[1,2\]. Evaluation for sensory neuropathy can be performed using Semmes–Weinstein monofilaments or biothesiometry. In resource-limited settings, simpler bedside methods—such as testing light touch with cotton wool, assessing pinprick sensation, and evaluating vibration perception using a 128 Hz tuning fork—are acceptable alternatives. The primary objective of sensory testing is to determine the presence of loss of protective sensation (LOPS), which significantly increases the risk of ulceration\[1,2\]. A handheld Doppler device may be employed to verify arterial flow and further assess vascular status. When combined with a sphygmomanometer, measurement of ankle and brachial systolic pressures allows calculation of the ankle–brachial index (ABI). Under normal circumstances, ankle systolic pressure slightly exceeds brachial pressure, yielding an ABI greater than 1. An ABI value below 0.9, particularly when accompanied by diminished or absent pulses, is indicative of peripheral arterial disease. Conversely, palpable pulses with an ABI above 1 generally exclude significant ischemia \[1,<https://pmc.ncbi.nlm.nih.gov/articles/PMC2878694/>,24\].
## Revascularization
Individuals presenting with significant peripheral ischaemia need re-establishment of arterial perfusion, as sufficient blood supply is critical for effective wound healing and eradication of infection. In cases of inadequate circulation tissue repair gets compromised the likelihood of limb loss drastically increases. Bypass surgery continues to be a well-recognised intervention for ischemic lower extremities, with durable long-term outcomes reported. Limb salvage rates of nearly 90% at 10 years have been documented following lower extremity bypass procedures \[1,2,22,23\]. In cases where arterial disease involves multiple segments, revascularization should target each level of obstruction to restore adequate distal blood flow and enhance the probability of limb preservation. Percutaneous transluminal angioplasty is particularly appropriate for discrete, short-segment stenotic lesions. Conversely, when disease is extensive—characterised by multiple occlusions, lesions longer than 15 cm, or infra-popliteal vessel involvement—bypass surgery is generally regarded as the treatment of choice. \[1,2\].
## Prevention
Timely identification of individuals at risk for ulceration plays a crucial role in preventing the development of diabetic foot lesions. An effective screening method includes- annual foot examinations for all patients with diabetes to initiate early intervention\[1,2\].Patient education forms the cornerstone of prevention strategies. Individuals should be counselled about strict glycemic control, use of appropriate footwear, avoiding foot trauma and routine self-inspection of the feet\[1,2\].
Preventive strategies may be categorised into three levels:
• **Primary prevention:** Identification of high-risk feet and provision of guidance regarding protective or therapeutic footwear.
• **Secondary prevention:** Early management of minor foot problems, including callus care, treatment of nail disorders, and appropriate handling of blisters or superficial lesions.
• **Tertiary prevention:** Early referral to specialised centers for advanced or complicated foot lesions \[1,2\].
Improved limb salvage rates and reduction in amputation incidence can be achieved through structured training of primary care physicians and paramedical staff in diabetic foot management. The “Step by Step” program, implemented by the World Diabetes Foundation, represents one such initiative \[1,2\].
Continuous patient education and long-term follow-up are essential for all individuals suffering with diabetes, especially diabetic foot ulcers. Such patients should be advised to limit excessive mechanical stress on the affected limb and adopt activity modifications when necessary\[1,2\].A comprehensive understanding of diabetic foot pathology, systematic foot examination, appropriate classification of ulcers, multidisciplinary management, and implementation of preventive measures collectively contribute to improved limb preservation and reduced amputation rates among individuals with diabetes\[1,2\].
# Conclusion
Diabetic foot disease remains a major and largely preventable cause of morbidity among individuals with diabetes mellitus and continues to contribute for a significant proportion of hospitalisation and non-traumatic lower-limb amputations worldwide. This literature review consistently demonstrates that diabetic foot complications arise from the interaction of peripheral neuropathy, peripheral arterial disease, infection, foot deformities and poor glycaemic control; additionally delayed presentation and inadequate preventive care further exacerbates disease severity and adversely affect clinical outcomes.
Evidence strongly supports the effectiveness of preventive strategies including routine foot screening, risk stratification, patient education, use of appropriate footwear and early referral to specialised diabetic foot clinics. Multidisciplinary care models involving surgeons, diabetologists, podiatrists, vascular specialists and wound care teams have been shown to significantly reduce ulcer recurrence and amputation rates. In terms of treatment, the literature highlights that successful management requires a structured stepwise approach consisting of optimal glycaemic control, aggressive infection management using culture-guided antimicrobial therapy, regular wound debridement, appropriate wound dressings and effective off-loading techniques such as total contact casting or customised orthotic devices. In patients with ischaemic limbs, timely vascular assessment and revascularisation procedures, either endovascular or surgical, play a crucial role in improving limb salvage. Advanced wound-care modalities, including negative pressure wound therapy, growth factor-based therapies, and skin substitutes have demonstrated promising adjunctive benefits in selected cases. In summary, diabetic foot disease is largely preventable and treatable when addressed through early detection, standardised treatment protocols and coordinated multidisciplinary care. Strengthening preventive services, ensuring timely surgical and vascular interventions and expanding access to comprehensive diabetic foot management programs remain essential steps in reducing the burden of amputations and improving long-term patient outcomes\[1,2\].
Generating HTML Viewer...
− Conflict of Interest
The authors declare no conflict of interest.
− Ethical Approval
Not applicable
− Data Availability
The datasets used in this study are openly available at [repository link] and the source code is available on GitHub at [GitHub link].